Floatz logo

PANTOPRAZOLE

Migraine, Hemicrania

Fondazione I.R.C.C.S. Istituto Neurologico Carlo BestaSmall moleculePhase 4 / ApprovedDormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Migraine, Hemicrania cohort.

Asset / SponsorPhaseRating
PREDNISONE TABLETS
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Phase 4BB
BROMAZEPAM
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Phase 4B

Same molecule, other indications

PANTOPRAZOLE is also rated in:

gastroesophageal reflux diseaseDormant
BB
Indicative ·
68 / 100
View asset →
Acute PsychosisDormant
BB
Indicative ·
66 / 100
View asset →
psychotic disorderDormant
B
Indicative ·
63 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →